Expression and immunogenicity of oncofetal antigen-immature laminin receptor in human renal cell carcinoma

Journal of Urology

Volumn 165, Issue 5 I, 2001, Pages 1705-1709

  Zelle Rieser, Claudia ^b   Barsoum, Adel L ^b   Sallusto, Federica ^b   Ramoner, Reinhold ^b   Rohrer, James W ^b   Höltl, Lorenz ^b   Bartsch, Georg ^b   Coggin Jr , Joseph H ^b   Thurnher, Martin ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b NONE

Author keywords

Antigens; Carcinoma, renal cell; Dendritic cells; Interleukin 10; Receptors, laminin

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; LAMININ RECEPTOR; ONCOFETAL ANTIGEN; TUMOR ANTIGEN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE ASSOCIATION; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOGENICITY; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 0035052212     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)66398-7     Document Type: Article

References (27)

1. Tumors express both unique TSTA and crossprotective 44 kDa oncofetal antigen
2. A 33-kDa polypeptide with homology to the laminin receptor: Component of translation machinery
3. Role of the 37 kDa laminin receptor precursor in the life cycle of prions
4. Studies of the structure of the metastasis-associated 67 kDa laminin binding protein: Fatty acid acylation and evidence supporting dimerization of the 32 kDa gene product to form the mature protein
5. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells
6. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas
7. Expression of 44-kilodalton oncofetal antigen as a premalignancy marker in X irradiation-induced murine T-cell lymphoma
8. The 67 kDa laminin receptor as a prognostic factor in human cancer
9. Mouse monoclonal antibody to embryonic antigen: Development, cross-reactivity with rodent and human tumors, and preliminary polypeptide characterization
10. 37 KiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers
11. Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, longterm survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning
12. CD8 T cell clones inhibit antitumor T cell function by secreting IL-10
13. Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes
14. Renal-cell carcinoma
15. CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer
16. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells
17. Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma
18. Host immune response in renal cell cancer: Interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes
19. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma
20. Human renal-cell carcinoma tissue contains dendritic cells
21. Interleukin-10
22. IL-10: A novel cytotoxic T cell differentiation factor
23. In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation
24. Dendritic cells as adjuvants for immune-mediated resistance to tumors
25. Major histo-compatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction
26. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose